58: Immunosuppressants Flashcards

1
Q

adverse effects of immunosuppression include..

A

infectious disease

malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MOA glucocorticoids

A
  • genomic effects (bind to cytosolic receptor, translocate to nucleus and bind DNA –> change expression)
  • non-genomic effects (influence signaling pathways, ion transport, rapid immunosuppressive effects (minutes))
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

effects of glucocorticoids

A
  • rapid decrease in peripheral blood lymphocytes
  • downregulate key pro-inflammatory cytokines
  • inhibit IL-2 production by t cells (required for proliferation)
  • reduce neutrophil chemotaxis and lysosomal enzyme release
  • little effect on humoral immunity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

therapeutic uses glucocorticoids

A
  • transplant rejection
  • graft v. host disease
  • cytokine storm in transplant caused by treatment with muromonab CD3 and antithymocyte globulin
  • autoimmune disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

adverse effects glucocorticoids

A
  • adrenal crisis upon rapid withdrawal
  • cataracts
  • avascular necrosis of bone
  • poor wound healing
  • growth retardation
  • hyperglycemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

prednisone equivalent =

A

amount of prednisone or its equivalent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
dosing glucocorticoids
low
medium
high 
very high 
pulse
A
less than 7.5 mg per day
7.5 - 30 mg per day
30 - 100 mg per day
greater than 100 mg  per day 
greater than 250 mg prednisone equivalent per day for 1 day or a few days
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MOA cyclosporine

A

suppresses t cell mediated immunity

forms a complex with cyclophilin which binds to calcineurin preventing the dephosphorlation of NFAT. NFAT cannot translocate to nucleus and cytokines including IL-2 does not occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

therapeutic uses cyclosporine

A

transplantation * not given renal because nephrotoxic
RA
psoriasis
combinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

adverse reactions cyclosporine

A
nephrotoxic
HTN
hyperlipidemia
tremors of hands and feet
swollen and painful gums
hirsuitism
skin cancer risk increased compared other immunosuppressives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

grapefruit juice and cyclosporine

A

cyclosporine blood concentrations can be increased by juice through inhibition of microsomal enzyme CYP3A and p-glycoprtn multidrug efflux pump

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

preferred calcineurin inhibitor for transplantation due to ease of blood level monitoring

A

tacrolimus

similar MOA to cyclosporine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

therapeutic use tacrolimus

A

prophylaxis of allograft rejection in solid-organ transplantation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

adverse reactions tacroliums

A
nephrotoxicity
hypertension
DM
neurotoxic
grapefruit juice contra
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

purine antimetabolite used to inhibit lymphocyte proliferation

A

azathioprine

metabolized to 6-mercaptopurine –> purine synthesis blocked

lymphocytes don’t have a salvage pathway for purines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

therapeutic uses for azathioprine

A

transplant rejection
RA
chron’s disease

17
Q

adverse reactions azathioprine

A

bone marrow suppression: leukopenia, thrombocytopenia, anemia
hepatotoxicity
infection risk
cancer risk

18
Q

MOA mycophenolate mofetil

A

prodrug hydrolyzed to selective inhibitor of inosine monophosphate dehydrogenase, required for de novo synthesis of guanine nucleotides –> selective inhibits lymphocyte proliferation because don’t have a salvage pathway

19
Q

use for mycophenolate mofetil

A

prevent transplant rejection
combo therapy
treat lupus

20
Q

adverse reactions mycophenolate mofetil

A

hematologic and GI

infections

congential abnormalities or spontaneous abortion with preggers

21
Q

MOA sirolimus

A

inhibits t-lymphoctye proliferation by binding to FKBP simialr to tacrolimus
however, rather than inhibiting calcineurin, complex binds and inhibits mTor –> essential for cell cycle progression

22
Q

therapeutic uses sirolimus

A

transplant rejections

renal transplant combo

23
Q

characteristic antithymocyte globulin

A

rabbit serum containing purified gamma globulin specific to human thymocytes (antibodies to molecules on surface) including CD3)

–> complement mediated cytotoxicity or inhibition of lymphocyte function by binding to cell surface markers

24
Q

therapeutic uses antithymocyte globulin

A

induction immunosuppression
prophylactic immunospurrpession
acute rejection

25
Q

what can be used to combat the ‘cytokine storm’ from antithymocyte globulin?

A

glucocorticoids to prevent

see fever, chills, malaise

muromonab also has this side effect s

26
Q

characteristics of muromonab-CD3

A

antibodies directed at CD3 cause the depletion of t lymphocytes therby causing immunosuppression

mouse antibody

27
Q

therapeutic uses muromonab CD3

A

circulating t cells disappear from blood in minutes

used to reverse glucocorticoid-resistant organ transplant rejection

only can be used once (body figures it out)

28
Q

chimeric monoclonal antibody containing a human constant region and murine variable region

A

infliximab

anti-TNFa reagent

29
Q

recombinant human IgG1 monocolonal

A

adalimumab

anti-TNFa reagent

30
Q

contains the lignad binding portion of human tNFa receptor fused to Fc portion of human IgG1

A

etanercept

anti-TNFa reagent

31
Q

what does TNFa do?

A

inflammatory cytokine

implicated in pathogenesis of RA and crohns